MS
Mark Schoenberg sold $2.9M of URGN stock
Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN), sold 60,677 shares of URGN stock worth $2.9M, per an SEC Form 4 filed Aug 24, 2026.
It was an open-market sale.
The trade happened on Aug 20, 2026, 4 days before it was made public.
URGN has moved -40.9% since the trade date, from $46.80 to $27.65 (Nov 20, 2026 close).
- Traded
- Aug 20, 2026
- Disclosed
- Aug 24, 2026
- Filing delay
- 4 days
- Price since
- -40.9%
- Role
- Chief Medical Officer
- Source
- SEC Form 4